Purdue Pharma Claims $10B Opioid Settlement, Files For Chapter 11 Bankruptcy
NEW YORK — OxyContin maker Purdue Pharma L.P. on Sept. 15 announced that it has reached an agreement in principle to settle its opioid litigation for more than $10 billion and...To view the full article, register now.
Already a subscriber? Click here to view full article